Cargando…
CNTs mediated CD44 targeting; a paradigm shift in drug delivery for breast cancer
The breast cancer is one of the most common cancer affecting millions of lives worldwide. Though the prevalence of breast cancer is worldwide; however, the developing nations are having a comparatively higher percentage of breast cancer cases and associated complications. The molecular etiology behi...
Autores principales: | Jain Singhai, Nidhi, Ramteke, Suman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083711/ https://www.ncbi.nlm.nih.gov/pubmed/32215290 http://dx.doi.org/10.1016/j.gendis.2019.10.009 |
Ejemplares similares
-
The paradigm shift for drug delivery systems for oral and maxillofacial implants
por: Pokrowiecki, Rafal
Publicado: (2018) -
Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
por: Aggarwal, Devesh, et al.
Publicado: (2023) -
Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems
por: Ndinguri, Margaret W., et al.
Publicado: (2012) -
Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery
por: Liu, Ruolan, et al.
Publicado: (2023) -
Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)